We are live on ! Find out more
PBE icon

Invesco Biotechnology & Genome ETF
PBE

82 hedge funds and large institutions have $133M invested in Invesco Biotechnology & Genome ETF in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 18 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 18

0.37% more ownership

Funds ownership: 30.5% → 30.87% (+0.37%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5% less funds holding

Funds holding: 86 → 82 (-4)

15% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 13

22% less capital invested

Capital invested by funds: $170M → $133M (-$36.9M)

Holders
82
Holders Change
-4
Holders Change %
-4.65%
% of All Funds
2.29%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
11
Increased
27
Reduced
18
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.63M
2
FIM
Freedom Investment Management
Connecticut
+$2.05M
3
Jane Street
Jane Street
New York
+$2.04M
4
VKH
Virtu KCG Holdings
New York
+$1.59M
5
Citadel Advisors
Citadel Advisors
Florida
+$1.5M

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$5.07M
2
Morgan Stanley
Morgan Stanley
New York
-$4M
3
UBS Group
UBS Group
Switzerland
-$2.96M
4
FAAS
First Allied Advisory Services
California
-$2.66M
5
Wells Fargo
Wells Fargo
California
-$750K
Name Holding Trade Value Shares
Change 		Change in
Stake
CWM
26
Concert Wealth Management
California
$1.14M +$1.39M +24,907 New
YIA
27
YHB Investment Advisors
Connecticut
$1.12M – – –
US Bancorp
28
US Bancorp
Minnesota
$1.08M -$34.1K -610 -3%
NDSI
29
Newman Dignan & Sheerar Inc
Rhode Island
$1.01M -$140K -2,500 -10%
WBG
30
Wharton Business Group
Pennsylvania
$860K – – –
Envestnet Asset Management
31
Envestnet Asset Management
Illinois
$847K +$169K +3,019 +19%
OPCM
32
Osborne Partners Capital Management
California
$822K – – –
Fiera Capital (Canada)
33
Fiera Capital (Canada)
Quebec, Canada
$771K +$943K +16,870 New
OIA
34
Optimum Investment Advisors
Illinois
$733K +$896K +16,030 New
BRWA
35
B. Riley Wealth Advisors
Florida
$566K +$368K +6,593 +114%
RJFSA
36
Raymond James Financial Services Advisors
Florida
$511K +$625K +11,181 New
AIG
37
American International Group
New York
$506K +$86.3K +1,544 +16%
BPC
38
Banque Pictet & Cie
Switzerland
$461K -$95K -1,700 -14%
Ameriprise
39
Ameriprise
Minnesota
$455K -$178K -3,179 -24%
Citigroup
40
Citigroup
New York
$448K -$27.9K -499 -5%
CFS
41
Commonwealth Financial Services
West Virginia
$422K – – –
WB
42
Webster Bank
Connecticut
$373K -$256K -4,575 -36%
Janney Montgomery Scott
43
Janney Montgomery Scott
Pennsylvania
$358K -$196K -3,503 -31%
Neuberger Berman Group
44
Neuberger Berman Group
New York
$346K – – –
LTFS
45
Ladenburg Thalmann Financial Services
Florida
$346K +$69.2K +1,238 +19%
CIC
46
Carnegie Investment Counsel
Ohio
$344K +$56 +1 +0%
Mirae Asset Global Investments
47
Mirae Asset Global Investments
South Korea
$325K +$83.8K +1,500 +27%
JIC
48
Joel Isaacson & Co
New York
$315K – – –
ICAS
49
Investors Capital Advisory Services
Massachusetts
$273K – – –
SFM
50
Signet Financial Management
New Jersey
$267K +$65.3K +1,169 +25%
1
2
3 4

PBE Hedge Fund Activity: Q3 2015 in Review

82 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Invesco Biotechnology & Genome ETF (PBE) for Q3 2015, worth a combined $133M — down 22% from $170M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of PBE and 11 opened new positions — a net loss of 2 holders — while 18 trimmed existing stakes and 27 added.

The largest buyer was Susquehanna International Group, adding an estimated $2.63M. The largest seller was Bank of America, cutting an estimated $5.07M.

  • 82 institutional investors held Invesco Biotechnology & Genome ETF (PBE) as of Q3 2015, down from 86 in Q2 2015.
  • Funds reported $133M of Invesco Biotechnology & Genome ETF stock for Q3 2015, down 22% quarter-over-quarter.
  • 11 funds opened new Invesco Biotechnology & Genome ETF positions in Q3 2015 and 13 closed out, a net change of -2 holders.
  • The largest Invesco Biotechnology & Genome ETF buyer in Q3 2015 was Susquehanna International Group, an estimated $2.63M added.
  • The largest Invesco Biotechnology & Genome ETF seller in Q3 2015 was Bank of America, an estimated $5.07M sold.

Based on aggregated 13F filings for Q3 2015.